NCT05508789 A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05486806 Longitudinal Tracking of Patients Diagnosed With Neurodegenerative Movement Disorders Status UNKNOWN Phase N/A
NCT05479981 Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients Status COMPLETED Phase PHASE2
NCT05452655 Intensive Multidisciplinary Rehabilitation and Biomarkers in Parkinson's Disease Status UNKNOWN Phase NA
NCT05418296 Assessing a Novel Virtual Environment That Assists With Activities of Daily Living Status COMPLETED Phase NA
NCT05357612 Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases Status RECRUITING Phase PHASE4
NCT05354622 Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) Status RECRUITING Phase N/A
NCT05321498 Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation Status WITHDRAWN Phase PHASE2
NCT05318976 A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation Status COMPLETED Phase PHASE2
NCT05245903 Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside Status RECRUITING Phase N/A